Early and late risk of ischemic stroke after TAVR as compared to a nationwide background population

In conclusion, TAVR was associated with an increased risk of ischemic CVE in the early phase, but not in the late phase, as compared to their matched con trols—OAC therapy reduced this early risk of ischemic CVE by half.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research